Table 1. Characteristics of patients included in serological analysis.
Diagnosis | Type* | N | Sex (F : FN : M : MN)† | Age (years : months) | |
Median | Range | ||||
Lymphoma | B-cell | 62 | 8 : 18 : 21 : 15 | 7 : 0 | 8 : 0–13 : 8 |
T-cell | 48 | 5 : 13 : 16 : 14 | 7 : 3 | 1 : 5–12 : 3 | |
Mixed | 1 | 0 : 1: 0 : 0 | 7 : 11 | 7 : 11 | |
Null-cell | 3 | 0 : 3: 0 : 0 | 6 : 7 | 6 : 6–8 : 4 | |
NOS | 44 | 7 : 9: 18 : 10 | 7 : 7 | 1 : 7–16 : 7 | |
Other cancer | Other | 37 | 2 : 17 : 6 :12 | 8 : 0 | 3 : 9–13 : 9 |
Control | Healthy | 39 | Unknown‡ | Unknown‡ | 1 : 0–8 : 0‡ |
NOS, not otherwise specified; patients with ‘Other’ cancers comprised: mast cell tumour (n = 12), sarcoma (n = 8), osteosarcoma (n = 6), carcinoma (n = 5), haemangiosarcoma (n = 2), and histiocytic tumour, melanoma, neuroectodermal bone tumour and thymoma (n = 1 each).
F, female; FN, female neutered; M, male; MN, male neutered.
The sex and exact age of these patients was not known, although all were aged between 1 and 8 years.